Skip to content

Clinical trials

Active, not recruiting Phase 1/2 Retinal Degeneration trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Retinal Degeneration Phase: Phase 1/2 Status: Active, not recruiting Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20182
20201
20232
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beacon Therapeutics1
Centro de Pesquisa Rubens Siqueira1
Elisigen, Inc.1
GenSight Biologics1
National Eye Institute (NEI)1
PYC Therapeutics1
SparingVision1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Retinal Degeneration7
Eye Diseases3
Retinal Diseases3
Retinal Dystrophies3
Retinitis Pigmentosa3
Cone-Rod Dystrophies2
Eye Diseases, Hereditary2
Choroidal Neovascularization1
Macular Degeneration1
Stargardt Disease1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.